Literature DB >> 35648447

Trousseau Syndrome in a 25-Year-Old Woman with Occult Colon Malignancy, Lynch Syndrome, and Chronic Thromboembolic Pulmonary Hypertension.

Caleb R Matthews1, Mackenzie Madison1, Chen Zhang2, Joshua Waters3, Jose P Garcia1, Daniel Beckman1.   

Abstract

We present a rare case of thrombosis associated with an occult colon malignancy (Trousseau syndrome) in a 25-year-old woman who also presented with previously unidentified Lynch syndrome and acute-on-chronic thromboembolic pulmonary hypertension. Staged treatment included bilateral pulmonary endarterectomy under deep hypothermic circulatory arrest, followed 11 days later by laparoscopic subtotal colectomy and creation of a primary anastomosis. The patient tolerated both procedures well and recovered normal functional status. Final pathologic analysis of the resected colon mass revealed a pT3N0, stage IIA adenocarcinoma; no adjuvant therapy was administered. At her one-year follow-up visit, the patient was cancer-free, remained on lifelong apixaban anticoagulation, and was undergoing routine monitoring and genetic counseling. This case highlights the need for multidisciplinary management of a patient with severe chronic thromboembolic pulmonary hypertension and a concomitant malignancy.
© 2022 by the Texas Heart® Institute, Houston.

Entities:  

Keywords:  Chronic disease/therapy; Lynch syndrome; colectomy; endarterectomy; hypertension, pulmonary/diagnosis/therapy; neoplasms/complications/surgery/therapy; pulmonary artery/physiopathology/surgery; pulmonary embolism/complications/diagnosis/physiopathology/surgery; risk factors; talc/adverse effects; thrombosis/etiology/therapy; venous thromboembolism/etiology/therapy

Mesh:

Year:  2022        PMID: 35648447      PMCID: PMC9242637          DOI: 10.14503/THIJ-20-7419

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  10 in total

1.  Cancer-associated thrombosis.

Authors:  Rodger L Bick
Journal:  N Engl J Med       Date:  2003-07-10       Impact factor: 91.245

Review 2.  Surgical Treatment of Chronic Thromboembolic Pulmonary Hypertension: Pulmonary Thromboendarterectomy.

Authors:  Michael M Madani
Journal:  Methodist Debakey Cardiovasc J       Date:  2016 Oct-Dec

3.  Molecular Basis Supporting the Association of Talcum Powder Use With Increased Risk of Ovarian Cancer.

Authors:  Nicole M Fletcher; Amy K Harper; Ira Memaj; Rong Fan; Robert T Morris; Ghassan M Saed
Journal:  Reprod Sci       Date:  2019-02-28       Impact factor: 3.060

4.  Outcome of pulmonary endarterectomy in symptomatic chronic thromboembolic disease.

Authors:  Dolores Taboada; Joanna Pepke-Zaba; David P Jenkins; Marius Berman; Carmen M Treacy; John E Cannon; Mark Toshner; John J Dunning; Choo Ng; Steven S Tsui; Karen K Sheares
Journal:  Eur Respir J       Date:  2014-09-18       Impact factor: 16.671

5.  Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy.

Authors:  A A Khorana; C W Francis; E Culakova; N M Kuderer; G H Lyman
Journal:  J Thromb Haemost       Date:  2007-03       Impact factor: 5.824

Review 6.  Chronic thromboembolic pulmonary hypertension (CTEPH): what do we know about it? A comprehensive review of the literature.

Authors:  Stefano Albani; Federico Biondi; Davide Stolfo; Francesco Lo Giudice; Gianfranco Sinagra
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2019-04       Impact factor: 2.160

Review 7.  Role of tissue factor in hemostasis, thrombosis, and vascular development.

Authors:  Nigel Mackman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-04-29       Impact factor: 8.311

8.  Risk factors for chronic thromboembolic pulmonary hypertension.

Authors:  D Bonderman; H Wilkens; S Wakounig; H-J Schäfers; P Jansa; J Lindner; I Simkova; A M Martischnig; J Dudczak; R Sadushi; N Skoro-Sajer; W Klepetko; I M Lang
Journal:  Eur Respir J       Date:  2008-09-17       Impact factor: 16.671

Review 9.  Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update.

Authors:  Gary H Lyman; Alok A Khorana; Nicole M Kuderer; Agnes Y Lee; Juan Ignacio Arcelus; Edward P Balaban; Jeffrey M Clarke; Christopher R Flowers; Charles W Francis; Leigh E Gates; Ajay K Kakkar; Nigel S Key; Mark N Levine; Howard A Liebman; Margaret A Tempero; Sandra L Wong; Ann Alexis Prestrud; Anna Falanga
Journal:  J Clin Oncol       Date:  2013-05-13       Impact factor: 44.544

Review 10.  Trousseau's syndrome: cancer-associated thrombosis.

Authors:  Soichiro Ikushima; Ryu Ono; Kensuke Fukuda; Masashi Sakayori; Nobuyasu Awano; Keisuke Kondo
Journal:  Jpn J Clin Oncol       Date:  2015-11-06       Impact factor: 3.019

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.